Abstract
Objectives: Women exposed prenatally to diethylstibestrol (DES) have an excess risk of clear-cell adenocarcinoma of the vagina and cervix, but the effect on the incidence of squamous neoplasia is uncertain. The purpose of the current study was to evaluate the long-term risk of developing high-grade squamous neoplasia of the genital tract among women exposed prenatally to DES.
Methods: A cohort comprising 3899 DES-exposed and 1374 unexposed daughters was followed for 13 years (1982–1995) for pathology-confirmed diagnoses of high-grade squamous intraepithelial neoplasia (HSIL) of the genital tract. Poisson regression analysis was used to compute relative risks (RR) and 95% confidence intervals (95% CI), adjusting for age, calendar year, and other covariates.
Results: The RR (95% CI) among DES-exposed versus unexposed, based on 111 cases of high-grade disease, was 2.1 (1.2–3.8). Adjustment for screening history estimated by the number of years since the last Pap smear had little effect. Risk estimates were higher with earlier intrauterine exposure; the RR (95% CI) for exposure within 7 weeks of the last menstrual period was 2.8 (1.4–5.5). Only two cases of invasive squamous cervical cancer occurred in total, precluding separate analysis.
Conclusions: The findings support an association between in-utero DES exposure and high-grade squamous neoplasia, although a role for more intensive screening among DES-exposed women in the production of this excess could not be completely ruled out.
Similar content being viewed by others
References
Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284: 878–881.
Robboy SJ, Kaufman RH, Prat J, et al. (1979) Pathologic findings in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 53: 309–317.
O'Brien P, Noller KL, Robboy SJ, et al. (1979) Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 53: 300–308.
Mattingly RF, Stafl A (1976) Cancer risk in diethylstilbestrol-exposed offspring. Am J Obstet Gynecol 126: 543–548.
Robboy SJ, Szyfelbein WM, Goellner JR, Kaufman RH, Taft PD, Richard RM (1981) Dysplasia and cytologic findings in 4,589 young women enrolled in Diethylstilbestrol-Adenosis (DESAD) Project. Am J Obstet Gynecol 140: 579–586.
Robboy SJ, Noller KL, O'Brien P, et al. (1984) Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project. JAMA 252: 2979–2983.
Verloop J, Rookus MA, van Leeuwen FE (2000) Prevalence of gynecologic cancer in women exposed to diethylstilbestrol in-utero. N Engl J Med 342: 1838–1839.
Hatch EE, Palmer JR, Titus-Ernstoff L, et al. (1998) Cancer risk in women exposed to diethylstilbestrol in-utero. JAMA 280: 630–634.
Labarthe D, Adam E, Noller KL, et al. (1978) Design and preliminary observations of the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 51: 453–458.
Dieckmann WJ, Davis ME, Rynkiewicz LM, Pottinger RE (1953) Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 66: 1062–1081.
Herbst AL, Hubby MM, Azizi F, Makii MM (1981) Reproductive and gynecologic surgical experience in diethylstibestrol-exposed daughters. Am J Obstet Gynecol 141: 1019–1028.
Baird DD, Wilcox AJ, Herbst AL (1996) Self-reported allergy, infection, and autoimmune diseases among women exposed to diethylstilbestrol. J Clin Epidemiol 49: 263–266.
Smith OW, Smith GVS (1949) The influence of diethylstilbestrol on the progress and outcome of pregnancy as based on a comparison of treated and untreated primigravidas. Am J Obstet Gynecol 58: 994.
Breslow NE, Day NE (1987) Statistical Methods in Cancer Research, vol. 2: The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer (IARC scientific publications no. 88).
Robboy SJ, Prat J, Welch WR, Barnes AB (1977) Squamous cell neoplasia controversy in the DES-exposed female. Human Pathol 8: 483–485.
Schiffman MH, Brinton LA, Devesa SS, Fraumeni JF (1996) Cervical cancer. In: Shottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press, pp. 1090–1116.
Noller KL, Townsend DE, Kaufman RH, et al. (1983) Maturation of vaginal and cervical epithelium in women exposed in-utero to diethylstilbestrol (DESAD Project). Am J Obstet Gynecol 146: 279–285.
Kalland T (1982) Long-term effects on the immune system of an early life exposure to diethylstilbestrol. In: Hunt VR, Smith MK, Worth D, eds. Environment factors in Human Growth and Development (Banbury Report no. 11). Cold Spring Harbor Laboratory, pp. 217–239.
Ford CD, Johnson GH, Smith WG (1983) Natural killer cells in in utero diethylstilbestrol-exposed patients. Gynecol Oncol 16:400–404.
Ways SC, Mortola JF, Zvaifler NJ, Weiss RJ, Yen SSC (1987) Alterations in immune responsiveness in women exposed to diethylstilbestrol in utero. Fertil Steril 48: 193–197.
Holladay SD, Blaycock BL, Comment CE, et al. (1993) Selective prothymocyte targeting by prenatal diethylstilbestrol exposure. Cell Immunol 152: 131–142.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hatch, E.E., Herbst, A.L., Hoover, R.N. et al. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control 12, 837–845 (2001). https://doi.org/10.1023/A:1012229112696
Issue Date:
DOI: https://doi.org/10.1023/A:1012229112696